Clinical trial design issues in the era of targeted therapies

Joan H. Schiller

doi:10.1158/1078-0432.CCR-040008

Clinical trial design issues in the era of targeted therapies

Joan H. Schiller

Internal Medicine

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

Although our lack of effective therapies mandates the development of new, molecularly targeted therapies, a number of issues in the design of clinical trials and their end points remain to be considered.

Original language	English (US)
Pages (from-to)	4281s-4282s
Journal	Clinical Cancer Research
Volume	10
Issue number	12 II
DOIs	https://doi.org/10.1158/1078-0432.CCR-040008
State	Published - Jul 15 2004

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-040008

Cite this

@article{b64f3536f1394482a0b1ce25732fc347,

title = "Clinical trial design issues in the era of targeted therapies",

abstract = "Although our lack of effective therapies mandates the development of new, molecularly targeted therapies, a number of issues in the design of clinical trials and their end points remain to be considered.",

author = "Schiller, {Joan H.}",

year = "2004",

month = jul,

day = "15",

doi = "10.1158/1078-0432.CCR-040008",

language = "English (US)",

volume = "10",

pages = "4281s--4282s",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "12 II",

}

TY - JOUR

T1 - Clinical trial design issues in the era of targeted therapies

AU - Schiller, Joan H.

PY - 2004/7/15

Y1 - 2004/7/15

N2 - Although our lack of effective therapies mandates the development of new, molecularly targeted therapies, a number of issues in the design of clinical trials and their end points remain to be considered.

AB - Although our lack of effective therapies mandates the development of new, molecularly targeted therapies, a number of issues in the design of clinical trials and their end points remain to be considered.

UR - http://www.scopus.com/inward/record.url?scp=3042536024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042536024&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-040008

DO - 10.1158/1078-0432.CCR-040008

M3 - Article

C2 - 15217975

AN - SCOPUS:3042536024

SN - 1078-0432

VL - 10

SP - 4281s-4282s

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 12 II

ER -

Clinical trial design issues in the era of targeted therapies

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this